FRACTYL HEALTH,.: TO DISCONTINUE INTERNAL DEVELOPMENT OF ITS REJUVA GENE THERAPY PROGRAM ,SEEKING STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE OF PROGRAM

Reuters · 1d ago

Please log in to view news